| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
4e-06 |
| mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
7e-06 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
4e-05 |
| mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
0.17 |
8e-05 |
| mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
8e-05 |
| mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.18 |
0.0001 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |